亚洲社会药学

本期目录

2015年, 第10卷, 第1期　刊出日期：2015-03-20 上一期    下一期

论文

Select

FDA’s Critical Path Initiative and Its Enlightenmentto Medical Device Market Access System in China LI Fei;;BI Kai-shun 2015 (1):  1-5.  doi: 摘要 ( 362 )   Objective To study FDA’s critical path initiative and summarize the methods and approaches that FDA has adopted to accelerate new medical device products into the market, thus to provide references for constructing a modernized medical device market access path in China. Methods Literature review was adopted to conduct a study of FDA’s critical path initiative. Results and Conclusion The methods FDA has mainly adopted in the process of implementing the critical path initiative include the following: the critical path initiative should be applied to identify the critical activities in medical device market access regulations; each critical activity should be analyzed and optimized; new and more reliable safety evaluation guidelines, tools and relevant standards should be developed so as to instruct the industry to pass through the critical path with higher probability and efficiency. 相关文章 | 计量指标

Select

On Digital Drug Management in One Hospital Pharmacy ZHOU Yan-ping;;LIAN Gui-yu 2015 (1):  6-8.  doi: 摘要 ( 380 )   Objective To explore the digital drug management model in hospital pharmacies and to ensure the drug use safety. Methods Digital drug management was studied by combining with the practices of drug management in one hospital pharmacy. Results and Conclusion The digital drug management of hospital pharmacies can optimize operation flow, improve the quality and efficiency of management, decrease dispensing errors, reduce the loss rates and improve the patients’ satisfaction. 相关文章 | 计量指标

Select

Incentive Measures and Performance Analysisof EU Paediatric Regulation ZHANG Qing-wen;YANG Yue 2015 (1):  9-18.  doi: 摘要 ( 420 )   Objective To introduce the incentive measures for paediatric drug research and development in European Union and to address the problem of lacking appropriate medicines for children. Methods Literature review was conducted through the PubMed, Web of Science and other database search by using the following key words, such as paediatric/pediatric drug development, incentives for paediatric/pediatric development and paediatric/pediatric regulation. Results and Conclusion The 2007 European Union (EU) Paediatric Regulation changed the status of lack of pediatric medicines in the EU by stimulating drug research and development through a series of incentive measures. The positive impact of the Pediatric Regulation on pediatric medicine development reflects an increase in the number of paediatric studies, drugs and information. 相关文章 | 计量指标

Select

An Research on Establishing the Systemof Drug Safety Mandatory Liability Insurance SHANG Li-yan 2015 (1):  19-22.  doi: 摘要 ( 360 )   Objective To reduce the damage of drug safety events through setting up the system of drug safety mandatory liability insurance. Methods Cost-profit theory in institutional economics was applied. Results and Conclusion It is necessary to set up drug safety mandatory liability insurance system in China, which can be achieved through legislation. 相关文章 | 计量指标

Select

Online Pharmacy Model Choice of Pharmaceutical Retail Chain Enterprises MENG Ling-quan;WU Zhi-ang;ZHOU Ying;CAO Jing 2015 (1):  23-29.  doi: 摘要 ( 434 )   Objective To study the development path of online pharmacies in China. Methods Development models of types of online stores were analyzed as references to explore suitable online pharmacy models for pharmaceutical retail chain enterprises. Results and Conclusion The pharmaceutical retail chain enterprises can adopt five models, such as the third party transaction model, to gain a quick development and to improve the service level. 相关文章 | 计量指标

Select

Current Status of Pharmaceutical Retail Market:Problems and Countermeasures WANG Jiao-nan;CHEN Yu-wen 2015 (1):  30-34.  doi: 摘要 ( 379 )   Objective To provide references for management and supervision of pharmaceutical retail market. Methods Current status of pharmaceutical retail market was analyzed and suggestions were raised to promote a healthy development of pharmaceutical retail market. Results and Conclusion Suggestions for the development of China’s pharmaceutical retail market are put forward from the two aspects of pharmaceutical retail enterprises and government supervision, including promoting rational distribution of chain pharmacies, encouraging the development of chain pharmacies, strengthening the licensed pharmacist system, implementing strictly the GSP certification system, etc. 相关文章 | 计量指标

Select

An Evaluation Study of Brand Competitiveness of Chain PharmaciesBased on the Analytic Hierarchy Process ZHANG Ji-wei;;WANG Shu-ling 2015 (1):  35-42.  doi: 摘要 ( 433 )   Objective To build up a scientific and rational evaluation system of brand competitiveness for chain pharmacies so that they can have an effective way to cultivate and manage their brand competitiveness. Methods Literature review and expert interviews were conducted to establish the basic framework for the evaluation system of brand competitiveness. The weight of first-level and secondlevel indicators was determined by AHP and expert scoring methods. Results and Conclusion After the consistency test, the weight coefficients of each indicator of the evaluation system are acceptable and they can be used as an effective tool to evaluate the brand competitiveness of chain pharmacies. Weight coefficients are also used as references for pharmaceutical retail chain enterprises to make decision in the brand cultivation. 相关文章 | 计量指标

Select

The Development of Chinese Medicinal Materials and DecoctionPieces Industry: Problems and Countermeasures WANG Jian-sheng;TIAN Li-juan 2015 (1):  43-49.  doi: 摘要 ( 411 )   Objective To analyze the problems in the development of Chinese medicinal materials and decoction pieces industry and to suggest the countermeasures. Methods Main factors that hinder the development of Chinese medicinal materials and decoction pieces industry were summarized through literature review and information collection. Results and Conclusion There are some problems in the development of Chinese medicinal materials and decoction pieces industry, especially in the areas of plantation and slices processing. Faking medicinal materials and decoction pieces are another serious problem. The development trend of Chinese medicinal materials and decoction pieces industry is good, though, it still needs the government’s guidance and policy support. 相关文章 | 计量指标

Select

E-commerce Marketing Models of Fisher Scientific Companyin Canada: Analysis and Its Enlightenment BAI Jian;LI Ye 2015 (1):  50-52.  doi: 摘要 ( 317 )   Objective To study the characteristics of Fisher Scientific Company’s e-commerce marketing models in Canada. Methods Fisher Scientific Company’s successful experience of e-commerce marketing models was explored from four aspects, including individualized sales service, highly integrated e-commerce platform, the e-commerce logistics system and the security of payment, meanwhile weaknesses of the related industries in China were also analyzed. Results and Conclusion Successful marketing experience from Fisher Scientific Company can be learned to promote the development of e-commerce in biological reagents marketing in China. 相关文章 | 计量指标